Key result
A survey of 251 physicians found hesitancy to prescribe oral anticoagulants for elderly patients with atrial fibrillation, with 51.4% believing the hemorrhage risk outweighs the benefits.
Why the study?
What are physicians' attitudes toward using oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation?
Cross-Sectional (n=251)
Yes
What are physicians' attitudes toward using oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation?
In 1991, physicians were hesitant to prescribe warfarin or aspirin for stroke prevention in elderly patients with atrial fibrillation unless an ischemic event had already occurred or mitral valve disease was present.
No takes yet. Share an insight, caveat, or question.
Physician reluctance may perpetuate undertreatment in elderly AF; leaves open whether contemporary guidelines or education have shifted these views.
M. Kutner (1991) conducted a cross-sectional in Atrial fibrillation (physician attitudes toward stroke prevention) (n=251). Oral anticoagulants (warfarin) and antiplatelet agents (aspirin) was evaluated on Physician reported use and attitudes toward warfarin and aspirin. A survey of 251 physicians found hesitancy to prescribe oral anticoagulants for elderly patients with atrial fibrillation, with 51.4% believing the hemorrhage risk outweighs the benefits.